Fingerprint The fingerprint is based on mining the text of the scientific documents related to the associated persons. Based on that an index of weighted terms is created, which defines the key subjects of research unit

Sarcoma Medicine & Life Sciences
Neoplasms Medicine & Life Sciences
Drug Therapy Medicine & Life Sciences
Doxorubicin Medicine & Life Sciences
Therapeutics Medicine & Life Sciences
Gastrointestinal Stromal Tumors Medicine & Life Sciences
Osteosarcoma Medicine & Life Sciences
Survival Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 1972 2019

A phase 1 and randomized controlled phase 2 trial of the safety and efficacy of the combination of gemcitabine and docetaxel with ontuxizumab (MORAb-004) in metastatic soft-tissue sarcomas

Jones, R. L., Chawla, S. P., Attia, S., Schöffski, P., Gelderblom, H., Chmielowski, B., Le Cesne, A., Van Tine, B. A., Trent, J. C., Patel, S., Wagner, A. J., Chugh, R., Heyburn, J. W., Weil, S. C., Wang, W., Viele, K. & Maki, R. G., Jan 1 2019, In : Cancer.

Research output: Contribution to journalArticle

Open Access
docetaxel
gemcitabine
Sarcoma
Confidence Intervals
Safety

Dendritic cell vaccination plus low-dose doxorubicin for the treatment of spontaneous canine hemangiosarcoma

Konduri, V., Halpert, M. M., Baig, Y. C., Coronado, R., Rodgers, J. R., Levitt, J. M., Cerroni, B., Piscoya, S., Wilson, N., DiBernardi, L., Omarbekov, Z., Seelhoff, L., Ravi, V., Douglass, L. & Decker, W. K., Jan 1 2019, (Accepted/In press) In : Cancer gene therapy.

Research output: Contribution to journalArticle

Open Access
Hemangiosarcoma
Doxorubicin
Dendritic Cells
Canidae
Vaccination
Osteosarcoma
Radiotherapy
Drug Therapy
Neoplasm Metastasis
Recurrence